ijms-logo

Journal Browser

Journal Browser

Advances in the Research of Alzheimer’s Disease and Dietary Neuroprotective Agents

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: closed (20 November 2024) | Viewed by 1212

Special Issue Editors


E-Mail Website
Guest Editor
Laboratory of Foodomics, Institute of Food Science Research (CIAL, UAM-CSIC), Nicolás Cabrera 9, 28049 Madrid, Spain
Interests: food analysis; metabolomics; functional ingredients; food by-products; extraction processes; natural products; chromatographic analysis; mass spectrometry; colon cancer; Alzheimer
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Anaesthesiology and Intensive Care Medicine, Technical University Munich, Ismaninger str. 22, 81675 Munich, Germany
Interests: electrophysiology; long-term potentiation; voltage-sensitive-dye imaging; Alzheimer; anesthetics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The incidence of dementia is increasing at an alarming rate, representing a major modern public health concern. Alzheimer’s disease (AD), a neurodegenerative disorder with a rising incidence among elderly people, is the most common form of dementia and is characterized by progressive cognitive impairment. The precise etiology of AD is not fully clarified but is known to be complex and multifactorial, with a notable overlap between familial and non-familial forms but also with different forms of dementia, e.g., vascular dementia.

AD is characterized by chronic, progressive neurodegeneration, which involves early synaptotoxicity and, only at later stages, overt neuronal loss and associated brain atrophy.

Beyond the conventional Ab- and tau-targeted approaches, current knowledge about the pathophysiology of AD continues to grow and new findings related to synaptic dysfunction and neuroinflammation are the current focus. Particularly, aberrant-activated microglia and neurotoxic astrocytes have been identified, and the involvement of the complement system in synaptic pruning mechanisms and mitochondrial dysfunction appear to be important mediators, all of which may contribute to synaptic loss and cognitive deficits, the hallmarks of AD.

Additionally, the identification of molecular links between Alzheimer’s disease, diabetes mellitus, and other neurodegenerative diseases, is likely to synergistically act in promoting AD pathology, and may help us to understand the early and late molecular mechanisms of AD.

Emerging evidence suggests that bioactive food ingredients (e.g., phytochemicals) may exert beneficial effects on the brain by protecting neurons against stress-induced injury, by suppressing neuroinflammation, and by improving cognitive function. Indeed, certain foods that are particularly rich in bioactive phytochemicals are thought to strongly influence the structure and function of the brain; such foods are commonly referred to as “brain foods”. These bioactives can exert their action by crossing the blood–brain barrier or influencing the brain–gut-microbiome axis. In this regard, the identification of neuroprotective food ingredients, their multiple targets, and their underlying mechanisms of action, has become a promising therapeutic strategy to complement pharmacological interventions for promoting brain health.

In this Special Issue of International Journal of Molecular Sciences, we aim to gather innovative and important findings and updated state-of-the-art research that provide a comprehensive view on the molecular mechanisms mediating the pathogenesis of AD. This a unique opportunity, and we invite you to submit original research articles, review articles, or clinical trials targeting the role of dietary phytochemicals on various aspects related to neurodegenerative disorders like AD, supporting the neuroprotective potential of food bioactive compounds. Detailing the mechanisms and their neurotoxic effects at the molecular level is essential for developing new treatment strategies urgently required to fight this devastating disease.

Dr. Gerardo Alvarez-Rivera
Prof. Dr. Gerhard Rammes
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurodegenerative disorders
  • brain health
  • brain–gut-microbiome axis
  • blood–brain barrier assays
  • anti-inflammatory activity
  • antichlolinergic activity
  • antioxidant activity
  • bioactive phytochemicals
  • mechanisms of neuroprotection
  • brain foods
  • neuroprotection

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

24 pages, 9092 KiB  
Article
The Effects of Sevoflurane and Aβ Interaction on CA1 Dendritic Spine Dynamics and MEGF10-Related Astrocytic Synapse Engulfment
by Qinfang Shi, Xingxing Wang, Arpit Kumar Pradhan, Thomas Fenzl and Gerhard Rammes
Int. J. Mol. Sci. 2024, 25(13), 7393; https://doi.org/10.3390/ijms25137393 - 5 Jul 2024
Viewed by 840
Abstract
General anesthetics may accelerate the neuropathological changes related to Alzheimer’s disease (AD), of which amyloid beta (Aβ)-induced toxicity is one of the main causes. However, the interaction of general anesthetics with different Aβ-isoforms remains unclear. In this study, we investigated the effects of [...] Read more.
General anesthetics may accelerate the neuropathological changes related to Alzheimer’s disease (AD), of which amyloid beta (Aβ)-induced toxicity is one of the main causes. However, the interaction of general anesthetics with different Aβ-isoforms remains unclear. In this study, we investigated the effects of sevoflurane (0.4 and 1.2 maximal alveolar concentration (MAC)) on four Aβ species-induced changes on dendritic spine density (DSD) in hippocampal brain slices of Thy1-eGFP mice and multiple epidermal growth factor-like domains 10 (MEGF10)-related astrocyte-mediated synaptic engulfment in hippocampal brain slices of C57BL/6 mice. We found that both sevoflurane and Aβ downregulated CA1-dendritic spines. Moreover, compared with either sevoflurane or Aβ alone, pre-treatment with Aβ isoforms followed by sevoflurane application in general further enhanced spine loss. This enhancement was related to MEGF10-related astrocyte-dependent synaptic engulfment, only in AβpE3 + 1.2 MAC sevoflurane and 3NTyrAβ + 1.2 MAC sevoflurane condition. In addition, removal of sevoflurane alleviated spine loss in Aβ + sevoflurane. In summary, these results suggest that both synapses and astrocytes are sensitive targets for sevoflurane; in the presence of 3NTyrAβ, 1.2 MAC sevoflurane alleviated astrocyte-mediated synaptic engulfment and exerted a lasting effect on dendritic spine remodeling. Full article
Show Figures

Figure 1

Back to TopTop